SurModics, Inc. is a leading provider of surface modification and drug delivery technologies to the healthcare industry. Our mission is to exceed our customers’ expectations and enhance the well-being of patients by providing the world’s foremost, innovative surface modification and drug delivery technologies and products. SurModics partners with many of the world’s leading and emerging medical device, pharmaceutical and life sciences companies to develop and commercialize innovative products designed to improve patient outcomes.

We are customer-focused and depend on continuous innovation to drive a business model which is primarily based on revenue generated through technology licenses. Through our technologies, our healthcare industry customers develop improved products or products with new functionality. Our core offerings include: drug delivery technologies (coatings, microparticles, and implants); surface modification coating technologies that impart lubricity, prohealing, and biocompatibility capabilities; and components for in vitro diagnostic test kits and specialized surfaces for cell culture and microarrays. Our strategy is to build on our technical leadership in the field of surface modification and drug delivery technologies and products, enabling us to strengthen our position as a leading edge product development partner to the healthcare industry.

SurModics’ technologies are utilized by our customers to either alter the characteristics of the surfaces of devices and biological materials or to enable drug delivery from coatings, implants or injected microparticles. Our key therapeutic focus areas include cardiovascular disease, ophthalmology and orthopedics.

Key Investment Characteristics

• Demonstrated leadership and expertise in the development of surface modification and drug delivery technologies
• Unique opportunity to drive convergence of drugs and medical devices; expanding to include polymer-based drug delivery
• Partner of choice for the world's leading medical device, pharmaceutical, and biotechnology companies
• Broad portfolio of proprietary platforms enables development, manufacture, and commercialization of breakthrough products
• Generating stronger customer relationships and enhanced agreement terms by moving up product development value chain
• Strong balance sheet with consistent record of growth, profitability and effective capital allocation
• Company focused on core values of customer partnership, innovation, integrity, entrepreneurship and responsibility

Points of Differentiation

• Long track record of innovation and bringing technologies to market rapidly
• Creative solutions to address unmet medical needs in the fields of surface modification and drug delivery
• Developed drug delivery coating for first-to-market drug-eluting stent
• Market-leading lubricious coating on broad range of customer medical devices
• Strong and varied customer base, including industry leaders as well as rapidly emerging growth companies
• Experienced technical staff with expertise in chemical engineering, biomedical engineering, bioanalytical chemistry, organic synthesis, protein chemistry, cell biology, enzyme technology, microbiology, genomics, immunoassay development, process development, and advanced surface characterization
• Proven clinical trial manufacturing capabilities
• Flexible business model with support throughout development and commercialization